Abstract 1843: Venetoclax-resistant AML cell models as a platform for exploring new generation drug for BCL2 inhibitor resistance.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Jinjin Wang, John Liu, Lin Teng
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148806611
Cites:
Cited by:
Related to: